Select the Industry/ Sector šŸ‘‰    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,107.9
₹55,478 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,459.9
₹43,234 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,981.6
₹32,597 Cr
Pharmaceuticals & Drugs
₹1,397.8
₹17,160 Cr
Pharmaceuticals & Drugs
₹795.2
₹15,630 Cr
Pharmaceuticals & Drugs
₹741.1
₹11,665 Cr
Pharmaceuticals & Drugs
₹927.6
₹8,411 Cr
Pharmaceuticals & Drugs
₹449.0
₹4,098 Cr
Pharmaceuticals & Drugs
₹264.4
₹2,961 Cr
Pharmaceuticals & Drugs
₹765.0
₹437 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹795.2
₹7,784 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,459.9
₹5,776 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹741.1
₹4,502 Cr
Pharmaceuticals & Drugs
₹449.0
₹2,678 Cr
Pharmaceuticals & Drugs
₹927.6
₹2,161 Cr
Pharmaceuticals & Drugs
₹3,981.6
₹1,593 Cr
Pharmaceuticals & Drugs
₹264.4
₹750 Cr
Pharmaceuticals & Drugs
₹26,107.9
₹7,004 Cr
Pharmaceuticals & Drugs
₹765.0
₹364 Cr
Pharmaceuticals & Drugs
₹1,397.8
₹2,590 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,459.9
₹1,135 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹795.2
₹688 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,981.6
₹439 Cr
Pharmaceuticals & Drugs
₹741.1
₹293 Cr
Pharmaceuticals & Drugs
₹927.6
₹232 Cr
Pharmaceuticals & Drugs
₹449.0
₹191 Cr
Pharmaceuticals & Drugs
₹264.4
₹172 Cr
Pharmaceuticals & Drugs
₹26,107.9
₹1,615 Cr
Pharmaceuticals & Drugs
₹765.0
₹23 Cr
Pharmaceuticals & Drugs
₹1,397.8
₹603 Cr

You may also like the below Video Courses